Healtheuniverse

Healtheuniverse was a biotechnology company focused on the development and commercialization of regenerative medicine and stem cell-based therapies. Operating primarily through its subsidiary, The Stem Cell Authority, the company provided processing and long-term storage services for adult stem cells derived from adipose tissue and bone marrow. Its research and service offerings targeted applications in cosmetic surgery, orthopedic repair, and cardiovascular treatments. The company aimed to bridge the gap between laboratory research and clinical application by offering a platform for physicians to integrate stem cell therapies into their practices. Although it was publicly traded under the symbol HLUN, the company has since ceased active operations and is considered defunct. Its business model was centered on the emerging field of autologous cell therapy during the mid-2000s.